Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation.
about
Rab1A is an mTORC1 activator and a colorectal oncogeneA family of transmembrane proteins with homology to the MET-hepatocyte growth factor receptorhTID-1 defines a novel regulator of c-Met Receptor signaling in renal cell carcinomasNovel p27(kip1) C-terminal scatter domain mediates Rac-dependent cell migration independent of cell cycle arrest functionsMet-HGF/SF signal transduction induces mimp, a novel mitochondrial carrier homologue, which leads to mitochondrial depolarizationNeutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal modelsUnderstanding and Targeting MET Signaling in Solid Tumors - Are We There Yet?Ligand-triggered resistance to molecular targeted drugs in lung cancer: roles of hepatocyte growth factor and epidermal growth factor receptor ligandsTargeting the epithelial to mesenchymal transition in glioblastoma: the emerging role of MET signalingBiology of MET: a double life between normal tissue repair and tumor progressionMet receptor tyrosine kinase: enhanced signaling through adapter proteinsHGF/SF-met signaling in the control of branching morphogenesis and invasionGab1 phosphorylation: a novel mechanism for negative regulation of HGF receptor signalingHepatocyte growth factor inhibits anoikis in head and neck squamous cell carcinoma cells by activation of ERK and Akt signaling independent of NFkappa BMET molecular mechanisms and therapies in lung cancerNormal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factorExpression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathwayMACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis.Co-overexpression of Met and hepatocyte growth factor promotes systemic metastasis in NCI-H460 non-small cell lung carcinoma cells.HGF/SF activates glycolysis and oxidative phosphorylation in DA3 murine mammary cancer cells.Src homology 2-containing inositol 5-phosphatase 1 binds to the multifunctional docking site of c-Met and potentiates hepatocyte growth factor-induced branching tubulogenesis.Appl1 is dispensable for mouse development, and loss of Appl1 has growth factor-selective effects on Akt signaling in murine embryonic fibroblastsA point mutation in the MET oncogene abrogates metastasis without affecting transformation.p90 ribosomal S6 kinase 2 promotes invasion and metastasis of human head and neck squamous cell carcinoma cells.Disassociation of met-mediated biological responses in vivo: the natural hepatocyte growth factor/scatter factor splice variant NK2 antagonizes growth but facilitates metastasis.c-Met signaling in the development of tumorigenesis and chemoresistance: potential applications in pancreatic cancerRegulation of P311 expression by Met-hepatocyte growth factor/scatter factor and the ubiquitin/proteasome system.Proliferation and invasion: plasticity in tumor cells.Differential expression of E-cadherin and beta catenin in primary and metastatic Wilms's tumoursThe von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cellsTensin-4-dependent MET stabilization is essential for survival and proliferation in carcinoma cells.The Hepatocyte Growth Factor Receptor: Structure, Function and Pharmacological Targeting in CancerDevelopment of c-MET pathway inhibitors.HSulf-1 modulates HGF-mediated tumor cell invasion and signaling in head and neck squamous carcinoma.Loss of glutathione peroxidase 3 expression is correlated with epigenetic mechanisms in endometrial adenocarcinoma.Activation of hepatocyte growth factor-met autocrine loop enhances tumorigenicity in a human lung adenocarcinoma cell line.The Molecular Crosstalk between the MET Receptor Tyrosine Kinase and the DNA Damage Response-Biological and Clinical AspectsThe role of the c-Met pathway in lung cancer and the potential for targeted therapy.Multiple mutations and bypass mechanisms can contribute to development of acquired resistance to MET inhibitors.Activation of the urokinase plasminogen activator/urokinase plasminogen activator receptor system and redistribution of E-cadherin are associated with hepatocyte growth factor-induced motility of pancreas tumor cells overexpressing Met.
P2860
Q24307749-CCDD8DBD-1FD0-4201-9057-93BE264355D7Q24318269-275C22F3-0A09-4DA4-8145-56A344E4BF0FQ24337462-54B9896D-23D1-48CB-9789-E4F3C7039111Q24540538-8F08D2AC-5CBE-4DE3-B315-3CB45CA7AEEEQ24550994-1D0DF54C-6B50-4F05-96A8-428731303904Q24629814-DFFAC7AC-EE1D-4645-8DCA-AD090A9237CEQ26748581-E8C44F56-663B-4E78-B350-5DCF83C221E2Q26829104-AC195FA6-EC4A-4D0B-9C97-BFA04BA80792Q27011423-16AA1887-0CC5-41D2-A45F-1A494CFAF1A6Q28085247-5BCCFE12-A26D-469C-A104-AE93F49AB33CQ28140219-497E1C42-E4AC-4657-9CA3-555C5C186A55Q28202466-E4AC9E79-FC40-4E25-B150-258A7032FCB5Q28213808-70EAF7EC-969E-4853-985E-AC7956E5982AQ28216726-1098C5BA-155F-4F7D-9AF0-E02A99E303E2Q28272688-7F494276-C434-4AE3-93D1-E5BD46CFB2ECQ28345285-2018316B-A2A3-48EC-A35D-15097A5265B8Q28505373-8641766A-1A62-4BE3-8E58-217E6367857AQ30157439-A5A09C40-FA3C-4995-B87D-CAE0F7543F26Q30492361-B66AD625-6A47-486A-86D3-1CC2BC478B71Q30929211-D8065B4F-C977-4928-A6CE-80D5772E2147Q31538849-287C2918-5A33-479F-9A50-16C791C387B8Q33673656-856D830B-0567-42E7-BDEB-44560FC92144Q33731936-D9CEACE1-3183-463E-8E02-A1F6E7A7E1CDQ33755364-B6589B08-4251-476D-84E5-3AF7F55E7657Q33786959-C99CCF6F-FA69-4FEA-BD04-C8070F6F9B36Q33886974-0C6AA888-CC0F-4288-AA42-88553FEDB3C7Q33888904-F8A3149C-0F71-4970-ABEE-4E2E9FAF37E8Q33906737-F45E43BC-204A-4DBE-BB88-836173FC1875Q33919211-CFEC1BA2-8D5A-4568-90B9-EEE61D8176B4Q33959078-79E55AE2-8757-49AC-B489-8C7C600F8BAFQ33984904-8DE45328-57E4-4E2E-81E1-CB9E41A1457CQ34141913-69EF638C-96C3-465B-B48A-656B28431FD8Q34198905-45C26BB7-1A6A-4E76-9224-C48C7052E0D6Q34299789-A2161D67-89CB-4DDE-90BD-262FE4E64EC6Q34461690-8B29FD58-4AD8-4C73-BF6E-37D16BC6C0D5Q34785157-90A9BF6E-F462-4A46-9BF6-166CDB740767Q35078950-8D1AEF53-23AF-4C27-9497-99B85282482FQ35146937-2C3AC006-B103-46AA-98CF-68BF3A74F87DQ35525305-0044848E-A79A-46DC-87AD-75DB0E762890Q35753150-A8A46CE9-7B24-4C63-845E-BBBB4044E763
P2860
Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation.
description
1994 nî lūn-bûn
@nan
1994 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Invasiveness and metastasis of ...... factor autocrine stimulation.
@ast
Invasiveness and metastasis of ...... factor autocrine stimulation.
@en
type
label
Invasiveness and metastasis of ...... factor autocrine stimulation.
@ast
Invasiveness and metastasis of ...... factor autocrine stimulation.
@en
prefLabel
Invasiveness and metastasis of ...... factor autocrine stimulation.
@ast
Invasiveness and metastasis of ...... factor autocrine stimulation.
@en
P2093
P2860
P356
P1476
Invasiveness and metastasis of ...... factor autocrine stimulation.
@en
P2093
P2860
P304
P356
10.1073/PNAS.91.11.4731
P407
P577
1994-05-01T00:00:00Z